Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NYSE:AGL NASDAQ:SGRY NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$98.09+1.5%$98.01$90.89▼$124.43$1.82B0.92241,243 shs49,477 shsAGLAgilon Health$59.19+112.5%$17.82$7.48▼$85.00$968.66M2.29337,161 shs2.62 million shsSGRYSurgery Partners$14.45-1.0%$13.34$11.41▼$24.18$1.89B1.991.57 million shs501,052 shsWGSGeneDx$38.86+12.0%$69.45$32.21▼$170.87$1.14B2.06938,202 shs2.71 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.83%-0.33%+3.36%-9.33%-11.39%AGLAgilon Health+4.43%-0.39%+99.40%+76.27%-75.20%SGRYSurgery Partners+2.31%+5.19%+18.62%+8.64%-36.59%WGSGeneDx+0.58%-44.82%-47.89%-58.72%-45.14%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$98.09+1.5%$98.01$90.89▼$124.43$1.82B0.92241,243 shs49,477 shsAGLAgilon Health$59.19+112.5%$17.82$7.48▼$85.00$968.66M2.29337,161 shs2.62 million shsSGRYSurgery Partners$14.45-1.0%$13.34$11.41▼$24.18$1.89B1.991.57 million shs501,052 shsWGSGeneDx$38.86+12.0%$69.45$32.21▼$170.87$1.14B2.06938,202 shs2.71 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.83%-0.33%+3.36%-9.33%-11.39%AGLAgilon Health+4.43%-0.39%+99.40%+76.27%-75.20%SGRYSurgery Partners+2.31%+5.19%+18.62%+8.64%-36.59%WGSGeneDx+0.58%-44.82%-47.89%-58.72%-45.14%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 2.73Moderate Buy$132.3334.91% UpsideAGLAgilon Health 2.13Hold$42.70-27.85% DownsideSGRYSurgery Partners 2.50Moderate Buy$22.1853.51% UpsideWGSGeneDx 2.67Moderate Buy$96.43148.14% UpsideCurrent Analyst Ratings BreakdownLatest AGL, WGS, SGRY, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026AGLAgilon Health Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$27.50 ➝ $48.005/7/2026AGLAgilon Health Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$33.00 ➝ $49.005/7/2026AGLAgilon Health Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$20.00 ➝ $35.005/6/2026SGRYSurgery Partners Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$17.005/6/2026ADUSAddus HomeCare Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$150.00 ➝ $142.005/5/2026WGSGeneDx Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$85.005/5/2026WGSGeneDx Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$100.00 ➝ $75.005/5/2026WGSGeneDx Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$155.00 ➝ $75.005/5/2026WGSGeneDx GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$100.00 ➝ $70.005/5/2026WGSGeneDx BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$170.00 ➝ $90.005/4/2026AGLAgilon Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral ➝ Underweight$21.00(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.42B1.29$6.47 per share15.16$59.80 per share1.64AGLAgilon Health$5.93B0.17N/AN/A$7.64 per share7.75SGRYSurgery Partners$3.31B0.57$1.73 per share8.35$24.21 per share0.60WGSGeneDx$442.68M2.57$2.58 per share15.06$8.68 per share4.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$95.91M$5.2118.0514.621.366.89%9.80%7.34%N/AAGLAgilon Health-$391.35M-$23.75N/AN/AN/A-6.60%-120.82%-24.89%N/ASGRYSurgery Partners-$77.90M-$0.62N/A60.21N/A-2.28%1.04%0.41%N/AWGSGeneDx-$21.02M-$2.68N/A22.86N/A-17.58%9.15%5.21%N/ALatest AGL, WGS, SGRY, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026AGLAgilon Health$1.04$1.80+$0.76$2.94$1.38 billion$1.42 billion5/5/2026Q1 2026SGRYSurgery Partners-$0.15-$0.03+$0.12-$0.28$797.69 million$810.90 million5/4/2026Q1 2026ADUSAddus HomeCare$1.52$1.62+$0.10$1.36$366.41 million$363.50 million5/4/2026Q1 2026WGSGeneDx-$0.06-$0.28-$0.22-$2.16$112.46 million$102.25 million3/2/2026Q4 2025SGRYSurgery Partners$0.31$0.12-$0.19-$0.12$866.54 million$885.00 million2/25/2026Q4 2025AGLAgilon Health-$0.27-$0.46-$0.19-$11.50$1.46 billion$1.57 billion2/23/2026Q4 2025WGSGeneDx$0.11$0.14+$0.03-$0.61$120.80 million$120.99 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAGLAgilon HealthN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.081.831.80AGLAgilon Health0.121.021.02SGRYSurgery Partners1.151.871.71WGSGeneDx0.383.092.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AGLAgilon HealthN/ASGRYSurgery PartnersN/AWGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%AGLAgilon Health2.30%SGRYSurgery Partners2.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare50,65918.67 million17.83 millionOptionableAGLAgilon Health1,07616.66 million16.28 millionNot OptionableSGRYSurgery Partners16,000130.80 million127.27 millionOptionableWGSGeneDx1,30029.29 million20.62 millionOptionableAGL, WGS, SGRY, and ADUS HeadlinesRecent News About These CompaniesBarrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud2 hours ago | globenewswire.comGENEDX HOLDINGS CORP. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudMay 6 at 8:00 PM | businesswire.comGeneDx (NASDAQ:WGS) Sees Large Volume Increase - Should You Buy?May 6 at 5:35 PM | marketbeat.comGeneDX Holdings Investigated for Possible Securities Fraud; Investors Should Contact Block & Leviton to Recover LossesMay 6 at 4:00 PM | newsfilecorp.comNINVESTOR ALERT: Investigation of GeneDx Holdings Corp. (WGS) announced by Holzer & Holzer, LLCMay 6 at 3:04 PM | globenewswire.comSecurities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities ...May 6 at 2:34 PM | tmcnet.comGeneDx Holdings Corp. 2026 Q1 - Results - Earnings Call PresentationMay 6 at 3:31 AM | seekingalpha.comWGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to ...May 5 at 11:00 PM | bakersfield.comBThe 'alarming' results that caused GeneDx stock to plummet 50%May 5 at 11:00 PM | msn.comWGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm's InvestigationMay 5 at 6:11 PM | globenewswire.comWGS stock slumps after hours as firm predicts lower test volume for yearMay 5 at 5:59 PM | msn.comSecurities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. CruzMay 5 at 5:59 PM | tmcnet.comDoes GeneDx’s Guidance Cut And Core Shift Reshape The Bull Case For GeneDx Holdings (WGS)?May 5 at 5:59 PM | finance.yahoo.comThe 'alarming' results that caused GeneDx stock to plummet 49%May 5 at 5:59 PM | msn.comSecurities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. CruzMay 5 at 3:33 PM | businesswire.comShareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp.May 5 at 2:58 PM | prnewswire.comGeneDx (NASDAQ:WGS) Reaches New 52-Week Low Following Weak EarningsMay 5 at 9:53 AM | marketbeat.comThe 'Alarming' Results That Caused GeneDx Stock To Plummet 45%May 5 at 9:35 AM | investors.comGuggenheim Cuts GeneDx (NASDAQ:WGS) Price Target to $70.00May 5 at 9:07 AM | marketbeat.comBTIG Research Cuts GeneDx (NASDAQ:WGS) Price Target to $90.00May 5 at 8:32 AM | marketbeat.comGeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesMay 5 at 8:09 AM | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026The War Won't Last Forever: 3 Stocks That Could Lead the RecoveryBy Bridget Bennett | April 8, 20265 Stocks Positioned to Win the AI Data Center BuildoutBy Bridget Bennett | April 20, 2026What the FDA's Latest Proposal Means for Lilly, Novo, and HimsBy Leo Miller | May 7, 2026AGL, WGS, SGRY, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$98.09 +1.45 (+1.50%) As of 12:27 PM Eastern This is a fair market value price provided by Massive. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Agilon Health NYSE:AGL$59.19 +31.34 (+112.52%) As of 12:27 PM Eastern This is a fair market value price provided by Massive. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Surgery Partners NASDAQ:SGRY$14.45 -0.14 (-0.96%) As of 12:26 PM Eastern This is a fair market value price provided by Massive. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.GeneDx NASDAQ:WGS$38.86 +4.15 (+11.96%) As of 12:27 PM Eastern This is a fair market value price provided by Massive. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Boarding Passes Now Being Issued for the Ultimate eVTOL Arbitrage DigitalOcean’s AI Surge: How Far Can This Rally Go? Fairy Dust Works: Disney's Stock Price Rises as Business Accelerates Apple Talks Just Changed Everything for Intel Consolidate or Die: Is Rivian The Ultimate Takeover Target? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
